The study looks at people with Asthma, a condition that makes breathing difficult because the airways become narrow and inflamed. The medication being used is an inhaled steroid called beclometasone dipropionate that is taken by inhalation to reduce airway swelling and improve breathing.

The aim is to describe how different patients experience the disease, how well their symptoms are controlled, and how the medicine and other treatments are used over time. Participants will be asked to attend regular visits where information about their health, use of inhalers, and any flare‑ups will be recorded, and simple breathing tests will be done to check changes in lung function. Blood or breath samples will also be collected to measure biomarkers that indicate the level of airway inflammation.

Over the study period, people will complete questionnaires about daily activities, sleep, and how asthma affects work or school, and doctors will note any visits to emergency services or hospitals. The collected data will help understand the relationship between the measured inflammation markers and the way symptoms change, without requiring any experimental procedures beyond routine care.